Abstract
The relationships between specific type IV pili (TFP) groups and antibiotic resistance, biofilm formation, and bacterial motility were determined in 190 Pseudomonas aeruginosa clinical isolates. While motility and biofilm formation were determined by phenotypic assays, the presence of TFP was determined by PCR assay and antibiotic susceptibility by disk diffusion. The results showed a high ability to form biofilm (97.4%), multidrug resistance (44.7%), and the presence of a high number of motile isolates. We also found an association between strong biofilm production and multidrug resistance. Furthermore, TFP group III was associated with strong biofilm production. In contrast, the isolates with TFP group II and those without any TFP were associated with non-strong biofilm production. Regarding motility, TFP group II was associated with higher percentages of swarming, swimming, and twitching, while TFP group I showed lower percentages of swarming and twitching, and TFP group III showed lower levels of swarming and swimming. In conclusion, these findings highlight the differences in P. aeruginosa phenotypes related to the presence of specific TFP groups and their potential implications in clinical settings.
References
Oct 29, 1998·Molecular Microbiology·G A O'Toole, R Kolter
Mar 4, 2000·Journal of Microbiological Methods·S StepanovicM Svabic-Vlahovic
Oct 6, 2000·Annual Review of Microbiology·G O'TooleR Kolter
Oct 13, 2000·Journal of Bacteriology·T KöhlerJ C Pechère
Mar 20, 2003·Journal of Bacteriology·Poney Chiang, Lori L Burrows
Jun 7, 2003·Molecular Microbiology·Mikkel KlausenTim Tolker-Nielsen
Jun 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Daniel J WozniakMatthew R Parsek
Dec 23, 2003·Infection and Immunity·Nathan E Head, Hongwei Yu
May 8, 2004·Journal of Clinical Microbiology·Samuel M MoskowitzJane L Burns
May 11, 2004·Microbiology·Julianne V KusLori L Burrows
Oct 25, 2006·Molecular Microbiology·Joshua D ShroutMatthew R Parsek
Sep 9, 2008·Journal of Bacteriology·Miranda L AsikyanLori L Burrows
Feb 10, 2010·BMC Microbiology·Elena DeligianniJames S G Dooley
May 26, 2010·FEMS Immunology and Medical Microbiology·Morten HarmsenTim Tolker-Nielsen
Aug 24, 2010·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Mohammad Mehdi FeizabadiMahmood Parvin
Jan 4, 2012·FEMS Microbiology Reviews·Ethan E Mann, Daniel J Wozniak
Jul 1, 2010·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Ivan MitovBoyka Markova
Mar 5, 2014·Canadian Journal of Microbiology·Cecily L HaleyAbdul N Hamood
Dec 4, 2014·Proceedings of the National Academy of Sciences of the United States of America·Morgen E AnyanJoshua D Shrout
Aug 26, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Antonio OliverCarlos Juan
Oct 20, 2015·Current Opinion in Microbiology·Barbara I KazmierczakRuchi Jain
Aug 5, 2016·The Indian Journal of Medical Research·Parul GuptaKusum Harjai
Feb 17, 2017·Archives of Microbiology·Letícia Muner OttonGertrudes Corção
Apr 14, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Niels HøibyOana Ciofu
May 1, 2017·International Journal of Hygiene and Environmental Health·Amélie VarinXavier Bertrand
Jul 19, 2017·Scientific Reports·Carla López-CausapéAntonio Oliver
Nov 15, 2017·Future Science OA·Fidelis EnyinnayaDavid R Woodard
May 16, 2018·Antimicrobial Agents and Chemotherapy·Marwa N AhmedOana Ciofu
Citations
Jul 28, 2019·Scientific Reports·Gertrudis HornaJoaquim Ruiz
Aug 16, 2019·Clinical Microbiology Reviews·Joaquim Ruiz
Feb 15, 2021·Microbiological Research·Gertrudis Horna, Joaquim Ruiz
Apr 4, 2021·International Journal of Molecular Sciences·Irene Jurado-MartínSiobhán McClean
May 1, 2021·Microbial Pathogenesis·Gertrudis Horna, Joaquim Ruiz
Sep 12, 2021·Infection & chemotherapy·Wilfredo Flores-ParedesJoaquim Ruiz